You are here: Industry Insights > Celonic

News List

Celonic Inaugurates “Next Generation” Biologics Development Center (BDC) and Pilot Plant in Basel, Switzerland Biotech Newswire
June 24, 2024
The Celonic Group, a Swiss Based Quality Biologics Contract Development and Manufacturing Organization (CDMO) today opened its “Next Generation” Biologics Development Center and Pilot Plant in Basel, Switzerland.
Samanta Cimitan Appointed Chief Executive Officer (CEO) at Celonic PharmaSources
August 03, 2023
On August 03, 2023，Celonic Group has appointed Dr. Samanta Cimitan as the Chief Executive Officer (CEO) of the Celonic Group, a subsidiary of the independent and privately owned J.RETTENMAIER & Söhne Company (JRS Group).
Celonic to Become a Long-Term Partner of the Federal Republic of Germany for Vaccine Supply b3cnewswire.com
March 28, 2022
The Federal Republic of Germany has announced its decision to sign contracts with Celonic AG and four other partners to secure the long-term supply of vaccines in Germany against Covid-19 and other pandemics...
Alexandre Pasini Appointed Chief Operating Officer (COO) at Celonic B3Cnewswire
October 29, 2021
Celonic Group, a Swiss-German contract development and manufacturing organization (CDMO), has appointed Alexandre Pasini as the new Chief Operating Officer of Celonic Group.
CureVac, Celonic Enter COVID-19 Vax Mfg. Pact contractpharma
March 31, 2021
Celonic is prepared to manufacture more than 100 million doses of CureVac’s mRNA-based COVID-19 vaccine candidate, CVnCoV, per year at Heidelberg facility.
Celonic to Boost Cell & Gene Therapy Production contractpharma
March 08, 2021
Celonic Group, a global contract development and manufacturing organization (CDMO) specialized in development and production of Advanced Therapy Medicinal Products (ATMP) and bio-therapeutics, has entered a long-term lease agreement for a new ...
Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine b3cnewswire
August 22, 2020
In the beginning of March this year Intravacc started working on the development of four candidate coronavirus vaccines based on three proprietary technologies: Vero cell, OMV and iBoost.
Intravacc, Celonic to Develop and Produce a Novel COVID-19 Vaccine americanpharmaceuticalreview
August 05, 2020
Intravacc and Celonic have signed a research agreement to further design, develop and produce a Covid-19 vaccine based on an immunogenic Spike (S) protein of SARS-CoV-2 combined with Intravacc’s prorietary Outer Membrane Vesicle (OMV) technology.
Intravacc and Celonic team up to develop Covid-19 vaccine pharmaceutical-technology
July 31, 2020
Intravacc has partnered with contract development and manufacturing organisation (CDMO) Celonic Group for the design, development and production of a Covid-19 vaccine.
Airway Therapeutics and Celonic Enter COVID-19 Collaboration contractpharma
May 26, 2020
Will make AT-100 as promising new candidate for coronavirus, production expected to begin in June.

Previous page 1 2 Next page